MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 70 filers reported holding MONTE ROSA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $63 | -33.0% | 13,171 | -3.4% | 0.00% | – |
| Q2 2023 | $94 | -20.3% | 13,635 | -10.1% | 0.00% | – |
| Q1 2023 | $118 | +93.4% | 15,169 | +89.9% | 0.00% | – |
| Q4 2022 | $61 | -99.4% | 7,988 | +556.9% | 0.00% | – |
| Q3 2022 | $10,000 | -28.6% | 1,216 | -15.6% | 0.00% | – |
| Q2 2022 | $14,000 | -89.1% | 1,440 | -84.2% | 0.00% | – |
| Q1 2022 | $128,000 | – | 9,108 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,472,331 | $7,052,465 | 2.91% |
| NEA Management Company, LLC | 7,692,298 | $36,846,107 | 2.85% |
| Octagon Capital Advisors LP | 812,895 | $3,893,767 | 0.60% |
| Alphabet Inc. | 1,464,015 | $7,012,631 | 0.45% |
| Avoro Capital Advisors LLC | 4,535,000 | $21,722,650 | 0.34% |
| Casdin Capital, LLC | 510,882 | $2,447,125 | 0.27% |
| Baker Brothers Advisors | 4,916,095 | $23,548,095 | 0.14% |
| Corton Capital Inc. | 14,460 | $69,263 | 0.04% |
| ExodusPoint Capital Management, LP | 619,248 | $2,966 | 0.03% |
| CORNERCAP INVESTMENT COUNSEL INC | 27,844 | $133,373 | 0.02% |